HSE Health Protection Surveillance Centre. (2022) Monitoring community HIV testing in Ireland, 2020. Dublin: HSE HPSC.
Preview | Title | Contact |
---|---|---|
|
PDF (Monitoring community HIV testing in Ireland, 2020.)
- Published Version
1MB |
Table 2 HIV test reactivity rate (%) and demographic characteristics, voluntary community-based testing in Ireland, 2019 (n=4,756) [Excludes testing at Balseskin Reception Centre] includes data for people who have ever injected drugs.
Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Substances (not alcohol/tobacco), Opioid
Intervention Type
Harm reduction
Date
September 2022
Pages
15 p.
Publisher
HSE HPSC
Corporate Creators
HSE Health Protection Surveillance Centre
Place of Publication
Dublin
EndNote
Subjects
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
J Health care, prevention, harm reduction and treatment > Identification and screening
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > Ireland
J Health care, prevention, harm reduction and treatment > Identification and screening
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page